C.H. Robinson to Acquire RXO in $5.8 Billion Stock-and-Cash Deal

C.H. Robinson entered an agreement to acquire RXO in a transaction valued at approximately $5.8 billion, with RXO shareholders receiving $17.25 in cash and 0.0856 C.H. Robinson shares per RXO share, or options for all-cash or all-stock consideration subject to proration. C.H. Robinson expects the combination to generate approximately $300 million in annual cost synergies within two years, with RXO shareholders owning about 11% of the combined company; closing is expected in the first half of 2027, subject to regulatory and RXO shareholder approvals, and the company has secured a $4.5 billion bridge financing commitment.